Relationship between diet and anticoagulant response to warfarin: a factor analysis. 2007

Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
Depto. de Nutrição e Dietética da Faculdade de Nutrição, Universidade Federal Fluminense (UFF), Rua São Paulo, 30/4 andar. Centro, Niterói, RJ 24015-110, Brazil. silviam@vm.uff.br

BACKGROUND Diet composition is one of the factors that may contribute to intraindividual variability in the anticoagulant response to warfarin. OBJECTIVE To determine the associations between food pattern and anticoagulant response to warfarin in a group of Brazilian patients with vascular disease. METHODS Recent and usual food intakes were assessed in 115 patients receiving warfarin; and corresponding plasma phylloquinone (vitamin K(1)), serum triglyceride concentrations, prothrombin time (PT), and International Normalized Ratio (INR) were determined. A factor analysis was used to examine the association of specific foods and biochemical variables with anticoagulant data. RESULTS Mean age was 59 +/- 15 years. Inadequate anticoagulation, defined as values of INR 2 or 3, was found in 48% of the patients. Soybean oil and kidney beans were the primary food sources of phylloquinone intake. Factor analysis yielded four separate factors, explaining 56.4% of the total variance in the data set. The factor analysis revealed that intakes of kidney beans and soybean oil, 24-h recall of phylloquinone intake, PT and INR loaded significantly on factor 1. Triglycerides, PT, INR, plasma phylloquinone, and duration of anticoagulation therapy loaded on factor 3. CONCLUSIONS Fluctuations in phylloquinone intake, particularly from kidney beans, and plasma phylloquinone concentrations were associated with variation in measures of anticoagulation (PT and INR) in a Brazilian group of patients with vascular disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010837 Vitamin K 1 A family of phylloquinones that contains a ring of 2-methyl-1,4-naphthoquinone and an isoprenoid side chain. Members of this group of vitamin K 1 have only one double bond on the proximal isoprene unit. Rich sources of vitamin K 1 include green plants, algae, and photosynthetic bacteria. Vitamin K1 has antihemorrhagic and prothrombogenic activity. Phylloquinone,Phytomenadione,Phytonadione,Aquamephyton,Konakion,Phyllohydroquinone,Vitamin K1
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D005163 Factor Analysis, Statistical A set of statistical methods for analyzing the correlations among several variables in order to estimate the number of fundamental dimensions that underlie the observed data and to describe and measure those dimensions. It is used frequently in the development of scoring systems for rating scales and questionnaires. Analysis, Factor,Analysis, Statistical Factor,Factor Analysis,Statistical Factor Analysis,Analyses, Factor,Analyses, Statistical Factor,Factor Analyses,Factor Analyses, Statistical,Statistical Factor Analyses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
October 2017, British journal of clinical pharmacology,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
August 2018, Scientific reports,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
June 1992, Annals of internal medicine,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
November 1989, The Journal of pharmacy and pharmacology,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
January 2008, Vitamins and hormones,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
January 2003, The pharmacogenomics journal,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
March 1996, The American journal of cardiology,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
March 2012, European journal of clinical pharmacology,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
June 1974, Journal of pharmaceutical sciences,
Silvia Maria Custódio das Dôres, and Sarah L Booth, and Ligia Araújo Martini, and Ligia Aújo Martini, and Victor Hugo de Carvalho Gouvêa, and Carlos Roberto Padovani, and Francisco Humberto de Abreu Maffei, and Alvaro Oscar Campana, and Sérgio Alberto Rupp de Paiva
August 1998, Research communications in molecular pathology and pharmacology,
Copied contents to your clipboard!